Personalized mRNA Vaccine After Digestive Cancer Surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a personalized mRNA vaccine designed to train your immune system to fight your specific cancer. It's for people who have just had surgery to remove a digestive system cancer (like pancreatic or colorectal) and will also receive standard chemotherapy after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have recently had surgery to remove a digestive system cancer (bile duct, pancreas, liver, stomach, or colorectal).
- After surgery, you are able to receive at least 4 rounds of standard chemotherapy.
- You must have a tumor tissue sample that is at least half a centimeter (about the size of a pea) to make the personalized vaccine.
- You are in good general health and able to care for yourself (ECOG score 0 or 1).
- You cannot have had other cancer treatments (like chemo or radiation) within 2 weeks before starting the vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized mRNA vaccine designed to target unique markers on your cancer cells. The vaccine is made just for you based on genetic testing of your tumor. It is for people with advanced digestive system cancers who have run out of standard options.
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) given alongside standard first-line treatment for advanced digestive system cancers. The vaccine is made specifically for your tumor's unique genetic changes (neoantigens) and aims to help your immune system fight the cancer more effectively.
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) made from your tumor's unique markers to help prevent cancer from coming back after surgery for bile duct or other digestive cancers. It may be an option if standard treatments have stopped working or caused side effects.
This trial tests a personalized mRNA vaccine made from your tumor’s unique genetic features. It is given after surgery to prevent the pancreatic cancer from coming back.
This trial tests a personalized mRNA vaccine designed to teach your immune system to attack your specific tumor. It is for people with advanced gastrointestinal cancers who have exhausted other options.
This trial tests a personalized mRNA vaccine made from your own tumor's unique markers (neoantigens). It is for people with advanced pancreatic cancer that has spread or come back, and who have had limited or no prior chemotherapy. The goal is to see if this vaccine can help the immune system fight the cancer.
Hear when a new Digestive System Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.